sequenom inc (SQNM:NASDAQ GS)
Harry F. Hixson Jr., Ph.D.
Former Chairman, Sequenom Inc.
|Age||Total Calculated Compensation||This person is connected to 12 board members in 2 different organizations across 7 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Harry F. Hixson, Jr., Ph.D. served as the Chief Executive Officer of Sequenom Inc. from September 28, 2009 to June 10, 2014. Dr. Hixson served as the Interim Chief Executive Officer of Sequenom Inc. Dr. Hixson Co-founded BrainCells Inc. and served as its Chief Executive Officer from July 2004 to September 2005. He served as the Chief Executive Officer of Elitra Pharmaceuticals Inc., from February 1998 to May 2003 and served as its President from June 1998 to May ...
3595 John Hopkins CourtPhone: 858-202-9000
San Diego, California 92121
Board Members Memberships*
Independent Director, Chairman of Science Committee and Member of Corporate Governance & Nominating Committee
The University of Chicago
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Harvey J. Berger M.D.||Principal Founder, Chairman, Chief Executive Officer and President|
Ariad Pharmaceuticals Inc.
|Ron Squarer BSc (Biochemistry), MBA||Chief Executive Officer and Director|
Array BioPharma Inc.
|Raul R. Rodriguez||Chief Executive Officer, President, Director and Member of Finance Committee|
Rigel Pharmaceuticals, Inc.
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|Michael A. Narachi M.S., M.B.A.||Chief Executive Officer, President and Director|
Orexigen Therapeutics, Inc.
|$640.6K||Compensation as of Fiscal Year 2014.|